Alzheimer’s Disease

New EIT Health projects in 2018

October 1, 2017

ETH Zurich is a partner in the European EIT Health Consortium. For 2018, three new projects with ETH participation will receive funding by the Consortium. In one of these [...]

Brain wellness

October 1, 2017

Alzheimer’s Disease, stroke and depression are among the most serious brain diseases. Lifestyle choices play an important role in their etiology. The new book by Hans-Ruedi [...]

Novel biomarker for AD

June 7, 2016

With the rapidly progressing development of therapies for Alzheimer’s Disease (AD) treatment, comes the need for sensitive diagnostics. Within the Oxford-McGill-ZNZ [...]

Rajendran receives SCOR Prize

June 7, 2016

Professor Lawrence Rajendran receives the SCOR Young Researcher European Grand Prize for his innovative research on Alzheimer’s disease (AD). Rajendran of the Systems and [...]

Specific inhibition of Aβ formation

June 7, 2016

BACE1, the enzyme involved in amyloid formation, is an important therapeutic target for Alzheimer’s Disease. Blocking BACE1 has, however, led to severe side effects. [...]

The immune system in AD

June 7, 2016

Dr. Maria Teresa Ferretti was awarded a three-year research grant from the Synapsis foundation to study the role of the immune system in Alzheimer’s disease. Together with [...]